Activist Investor Vs. Japan Pharma: ASKA Plans Poison Pill As Dalton Pushes For MBO

 
• By Lisa Takagi
  
ASKA vs. Dalton
ASKA the latest Japanese pharma firm to tussle with active foreign investor (Shutterstock)

More from Strategy

More from Japan